慢性淋巴细胞白血病患者全关节置换术后的内科与假体相关并发症
该研究比较了慢性淋巴细胞白血病(CLL)与非CLL患者行全关节置换术后的结局。CLL患者90天内内科并发症(如肺炎、心肌梗死、急性肾损伤)的 odds 显著更高,假体周围骨折、机械性松动、假体周围感染风险增加,住院时间更长、90天再入院率更高,且全髋翻修早于全膝。作者认为骨科医生应考虑CLL状态以进行知情咨询和并发症 mitigation。
要点
- CLL患者全膝置换术后90天肺炎OR 9.2、心肌梗死OR 5.5,均P<0.001。
- CLL患者全髋置换术后90天肺炎OR 10.0、急性肾损伤OR 6.3,均P<0.001。
- CLL患者假体周围骨折、机械性松动、假体周围感染风险增高,住院更长、再入院更多。
核心结论
- 骨科医生应基于CLL状态进行知情患者咨询和并发症 mitigation。
研究设计与样本
- 利用诊断和操作代码识别接受全膝置换(TKA)和全髋置换(THA)的CLL病例,按人口学和合并症以1:5比例匹配对照。
主要发现
- CLL TKA患者假体周围骨折、机械性松动和假体周围感染 odds 更高,THA患者假体周围骨折增加。
- THA翻修早于TKA(337±547天 vs 643±774天)。
临床怎么用
- 作者认为骨科医生应基于CLL状态进行知情患者咨询和并发症 mitigation。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic lymphocytic leukemia (CLL) is highly prevalent in the total joint arthroplasty age group but has not been properly evaluated. This study aimed to assess the following: 1) 90-day medical complications, 2) implant-related complications, 3) healthcare utilization, and 4) time to revision in CLL and non-CLL total joint arthroplasty. METHODS: The CLL cases undergoing total knee arthroplasty (TKA) and total hip arthroplasty (THA) were identified using diagnostic and procedural codes. The CLL TKA and THA patients were matched in a 1:5 ratio, with controls based on demographics and comorbidities. The outcomes included 90-day medical complications, 2-year implant complications, length of stay, 90-day readmission, and time to revision. RESULTS: The CLL TKA patients had significantly higher odds of 90-day medical complications compared to controls, notably pneumonia (OR [odds ratio], 9.2; CI [confidence interval], 7.1 to 12.0; P < 0.001) and myocardial infarction (OR, 5.5; CI, 3.9 to 7.9; P < 0.001). Similarly, CLL THA patients had greater odds of 90-day medical complications, especially pneumonia (OR 10.0; CI 8.2 to 12.2; P < 0.001) and acute kidney injury (OR 6.3; CI 5.1 to 7.8; P < 0.001). The CLL TKA patients faced higher odds of periprosthetic fracture, mechanical loosening, and prosthetic joint infection, while THA patients had increased periprosthetic fractures. Revisions occurred earlier for THA than TKA (337 ± 547 versus 643 ± 774 days). The CLL patients had longer length of stay(TKA: 5.9 ± 6.5 versus 3.1 ± 1.6 days; P < 0.001) (THA: 6.3 ± 12.9 versus 3.0 ± 2.4; P < 0.001) and higher 90-day readmission rates (OR, 1.3; CI, 1.1 to 1.5, P < 0.001). CONCLUSIONS: Orthopaedic surgeons should consider CLL status for informed patient counseling and complications mitigation.
引用
- Rodriguez HC, Mekkawy KL, Rust BD, et al. Medical- and Implant-Related Complications Following Total Joint Arthroplasty in Patients Who Have Chronic Lymphocytic Leukemia. J Arthroplasty. 2024. PMID: 39389235. doi:10.1016/j.arth.2024.09.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。